Mongalin, Baby Girl A.
HRN: 24-70-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2024
03/29/2024
IV
35
Q24
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes